Dynamic Visual Acuity of Patients with Neuritis Vestibularis

Dynamic Visual Acuity of Patients with Neuritis Vestibularis - Dynamic Visual Acuity - Neuritis Vestibularis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON32558

Enrollment

Registered

2009-12-16

Start date

2010-04-13

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infection of the inner ear Neuritis Vestibularis

Interventions

The dynamic visual acuity test and questionnaires.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Neuritis Vestibularis patient for not longer than a year - Living in or close to Apeldoorn - Control subjects: age and gender matched to patients

Exclusion criteria

Exclusion criteria: Younger than 18 years

Design outcomes

Primary

Measure	Time frame
The primary independent variable is whether the participant has been diagnosed with Neuritis Vestibularis, and if so, at which side. The primary dependent variable is the threshold per subtest. We are particularly interested in the threshold values of the VOR subtests (where the test symbol is presented when the head moves from left to right or the other way around) with respect to the static baseline subtest.	—

Measure

Time frame

The primary independent variable is whether the participant has been diagnosed with Neuritis Vestibularis, and if so, at which side. The primary dependent variable is the threshold per subtest. We are particularly interested in the threshold values of the VOR subtests (where the test symbol is presented when the head moves from left to right or the other way around) with respect to the static baseline subtest.

—

Secondary

Measure	Time frame
A secondary independent variable is when Neuritis Vestibularis developed and to what extent the patient still experiences problems (as measured through the questionnaires).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)